Market size and development trend of the pharmaceutical industry:
global marketThe size of the global pharmaceutical market increased from $1266.7 billion to $1474.7 billion from 2018 to 2022, with a compound annual growth rate of 3.9%. The global pharmaceutical market is expected to reach a size of approximately $1.5 trillion in 2023 and is projected to grow to $2.11 trillion by 2030, with a compound annual growth rate of 4.03% from 2024 to 203012.
Chinese marketIn 2022, the scale of China's pharmaceutical market reached 565.3 billion yuan, a year-on-year increase of 16.05%. The market size in 2023 is 650.6 billion yuan, a year-on-year increase of 15.09%. It is expected that the size of China's pharmaceutical market will remain stable between 10% and 15% from 2024 to 2030, and by 2030, the size of China's pharmaceutical market will exceed 1.5 trillion yuan3.
Driven by technological innovation：
The application of artificial intelligenceThe application of AI technology in drug research and development, design, screening, clinical trials, and production is becoming increasingly widespread, which can accelerate the drug discovery and design process, improve research and development efficiency and success rate, and reduce research and development costs and time
Breakthroughs in BiotechnologyThe continuous development of fields such as gene editing, cell therapy, and biosimilars has provided new means and methods for treating some difficult and complicated diseases, promoting the rapid growth of the biopharmaceutical market2.
Changes in market demand：
The aging population is intensifying: The accelerated aging of the global population has led to an increase in the incidence rate of chronic diseases, such as cardiovascular diseases, diabetes, cancer, etc., which has promoted the increase in demand for related therapeutic drugs and medical services3.
The Rise of Emerging MarketsThe economic development of emerging markets such as India, China, Brazil, and Africa, coupled with the rise of the middle class, has led to an increasing demand for high-quality healthcare services and rising healthcare expenditures, driving the expansion of the pharmaceutical market and providing new profit growth points for pharmaceutical companies3.
Policy environment impact：
Medical insurance cost control and quantity based procurement of drugsEncourage pharmaceutical companies to pay more attention to cost control and production efficiency improvement, promote technological innovation and management optimization to enhance product competitiveness
Encourage innovation policiesGovernments around the world have introduced a series of policies to encourage innovation, such as research and development subsidies, tax incentives, and accelerated review and approval, which have stimulated the innovation enthusiasm of pharmaceutical companies and accelerated the research and development and marketing process of innovative drugs3.
Industrial restructuring：
Consolidate the dominant position of large enterprisesLarge pharmaceutical companies dominate the market with their brand advantages, research and development capabilities, and market channels, and are able to continuously launch innovative drugs and quickly capture the market3.
Differentiated competition among small and medium-sized enterprisesSmall and medium-sized pharmaceutical enterprises have shown strong competitiveness in some segmented fields, such as infusion solutions, pharmaceutical distribution, blood products, etc., through characteristic products and differentiated competition, actively competing for market share3.
International Cooperation and Competition：
Overseas strategyWith the overall strength of domestic pharmaceutical companies increasing and the intensification of domestic market competition, more and more Chinese pharmaceutical companies are implementing the "going global" strategy, expanding the application scope and market influence of their products through cooperation with international enterprises or independent exploration of international markets13.
Global competition intensifiesThe competition in the global pharmaceutical market is becoming increasingly fierce, and companies need to continuously improve their core competitiveness, including research and development capabilities, production quality, market promotion, etc., in order to occupy a place in the international market13.
Green and sustainable developmentPharmaceutical companies are facing increasing environmental pressure and need to pay more attention to energy conservation, emission reduction, and resource recycling in their production processes to reduce their carbon footprint and achieve green and sustainable development